Adult Patients With Stage IIB, IIC, and Stage III Melanoma Following Complete Resection (Adjuvant Settings)
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pharmacokinetics, Safety, and Immunogenicity of Bmab1800 and Keytruda® as Adjuvant Monotherapy in Patients With Melanoma (NCT07581509) | Biocon Biologics UK PLC | 2026-08-01 |
Track Adult Patients With Stage IIB, IIC, and Stage III Melanoma Following Complete Resection (Adjuvant Settings) automatically
Every clearance here is in the API, with alerts when new ones post.